Evaluation in Real World of Molecular Testing and Treatment Patterns for EGFR mutation in Lung Cancer Patients

Trial Identifier: D133FR00143
Sponsor: AstraZeneca
NCTID:: NCT03721289
Start Date: November 2018
Primary Completion Date: March 2019
Study Completion Date: March 2019
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Argentina CABA, Argentina
Argentina Cordoba, Argentina
Argentina La Plata, Argentina
Argentina Rosario, Argentina
Chile Santiago de Chile, Chile
Colombia Bogota, Colombia
Colombia Cali, Colombia
Colombia Medellín, Colombia
Colombia Monteria, Colombia
Uruguay Montevideo, Uruguay